Clearside Biomedical (NASDAQ:CLSD) Upgraded at StockNews.com
Clearside Biomedical (NASDAQ:CLSD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a report released on Saturday. Other equities analysts have also issued reports about the company. JMP Securities reissued a “market outperform” rating and issued a $5.00 price objective on shares of Clearside […]
Clearside Biomedical (NASDAQ:CLSD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a report released on Saturday. Other equities analysts have also issued reports about the company. JMP Securities reissued a “market outperform” rating and issued a $5.00 price objective on shares of Clearside […]
